Ocugen Inc (OCGN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $280.88M
Last updated: Nov 17, 2026 at 11:05 AM ET
Ocugen Inc (OCGN) Stock Forecast
Analysts expect Ocugen (OCGN) to earn -$0.21 per share in the fiscal year ending Dec 31, 2026, on revenue of $5.79M. Of 6 analysts, 6 rate the stock Buy or Strong Buy, 0 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 6 ratings average 1.83, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 100% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 16.7% |
| Buy | 5 | 83.3% |
| Hold | 0 | 0.0% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 6
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 26.6%.
- Fiscal year ending Dec 31, 2026
- -$0.21
- EPS consensus, revenue $5.79M
- Fiscal year ending Dec 31, 2027
- -$0.18
- EPS consensus, revenue $7.33M
- Next report
- Mar 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.21 | -$0.22 to -$0.20 | 5 | $5.79M | $4.97M to $6.92M | 6 |
| Dec 31, 2027 | -$0.18 | -$0.18 to -$0.18 | 1 | $7.33M | $4.00M to $12.00M | 3 |
Quarterly Estimates
The EPS consensus falls from -$0.06 for the quarter ending Dec 31, 2026 to -$0.07 for the quarter ending Mar 31, 2027.
EPS range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | -$0.06 | -$0.07 to -$0.04 | 8 | $1.71M | N/A | 8 |
| Mar 31, 2027 | -$0.07 | -$0.08 to -$0.06 | 3 | $1.10M | $1.00M to $1.20M | 2 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 2 upward and 0 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 1 | 0 |
| Fiscal year ending Dec 31, 2027 | 1 | 0 |
| Quarter ending Mar 31, 2027 | 0 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$0.26.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$0.21 | -$0.26 | -$0.26 | -$0.26 | -$0.26 | N/A |
| Fiscal year ending Dec 31, 2027 | -$0.18 | -$0.25 | -$0.25 | -$0.27 | -$0.23 | N/A |
| Quarter ending Mar 31, 2027 | -$0.07 | -$0.08 | -$0.08 | -$0.08 | -$0.08 | N/A |
Frequently Asked Questions About OCGN
What is the OCGN stock forecast?
Consensus analyst estimates put Ocugen's EPS at -$0.21 for the fiscal year ending Dec 31, 2026, on revenue of $5.79M. The consensus rating from 6 analysts is Buy.
How do analysts rate OCGN stock?
Of 6 analysts covering Ocugen, 1 rates it Strong Buy, 5 Buy, 0 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from OCGN next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$0.21, with estimates from -$0.22 to -$0.20 from 5 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$0.18, with estimates from -$0.18 to -$0.18 from 1 analyst.
What revenue do analysts expect from Ocugen next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $5.79M, with estimates from $4.97M to $6.92M. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $7.33M, with estimates from $4.00M to $12.00M.
How many analysts cover OCGN?
6 analysts rate Ocugen stock, and 5 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
OCGN pages: Overview, Earnings, Forecast, Financials, Competitors